Author: healthylife7

Eli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge following the news of these discussions. The company focuses on mental health treatments using psychedelic-based compounds. AtaiBeckley is developing an intranasal formulation for treatment-resistant depression. Talks are ongoing, and a deal could be announced this week

Read More

Opening the session, Joe Chou, Deputy Secretary General of TAITRA, and Dr Sang-Ju Yu, Honorary President of the Taiwan Society of Home Health Care, set the tone with a shared conviction: ‘The future of care cannot rely exclusively on hospitals,’ and that realising this future will require both innovative technology and a fundamental willingness to…

Read More

Rituals expands Mind Oasis with premium at-home wellbeing system – TheIndustry.beauty Partner with us ‘); }); jQuery(‘#-pro-menu-10-185148 .oxy-pro-menu-show-dropdown .menu-item:not(.menu-item-has-children) > a’, ‘body’).each(function(){ jQuery(this).append(”); }); ‘); }); jQuery(‘#-pro-menu-14-15 .oxy-pro-menu-show-dropdown .menu-item:not(.menu-item-has-children) > a’, ‘body’).each(function(){ jQuery(this).append(”); });

Read More